GL9 logo

Glanbia plc Stock Price

ISE:GL9 Community·€3.5b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 18 Fair Values set on narratives written by author

GL9 Share Price Performance

€14.38
-0.37 (-2.51%)
€20.45
Fair Value
€14.38
-0.37 (-2.51%)
30.2% undervalued intrinsic discount
€20.60
Fair Value
Price €14.38
AnalystHighTarget €20.60
AnalystLowTarget €13.00
AnalystConsensusTarget €17.81

GL9 Community Narratives

AnalystHighTarget·
Fair Value €20.45 29.7% undervalued intrinsic discount

Digital And Plant Based Nutrition Will Expand Global Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystLowTarget·
Fair Value €12.27 17.2% overvalued intrinsic discount

Plant-based Trends And ESG Pressures Will Weaken Dairy Demand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value €17.81 19.2% undervalued intrinsic discount

Expanding Health And Dairy Nutrition Will Unlock Global Demand

0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
€12.27
17.2% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
2.1% p.a.
Profit Margin
8.13%
Future PE
11.36x
Share price in 2028
€14.27

Updated Narratives

GL9 logo

Expanding Health And Dairy Nutrition Will Unlock Global Demand

Fair Value: €17.81 19.2% undervalued intrinsic discount
16 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GL9 logo

Plant-based Trends And ESG Pressures Will Weaken Dairy Demand

Fair Value: €12.27 17.2% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GL9 logo

Digital And Plant Based Nutrition Will Expand Global Markets

Fair Value: €20.45 29.7% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet average dividend payer.

3 Risks
3 Rewards

Glanbia plc Key Details

US$4.0b

Revenue

US$2.9b

Cost of Revenue

US$1.1b

Gross Profit

US$966.1m

Other Expenses

US$120.8m

Earnings

Last Reported Earnings
Jul 05, 2025
Next Reporting Earnings
n/a
0.50
27.51%
3.06%
45.2%
View Full Analysis

About GL9

Founded
1964
Employees
5791
CEO
Hugh McGuire
WebsiteView website
www.glanbia.com

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; property leasing; and provision of business services and management solutions, weight management, flavor solutions, and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, SlimFast, think!, Amazing Grass, Body & Fit, and LevlUp brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

Recent GL9 News & Updates

With Glanbia plc (ISE:GL9) It Looks Like You'll Get What You Pay For

Sep 23
With Glanbia plc (ISE:GL9) It Looks Like You'll Get What You Pay For

Recent updates

No updates